Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Operating Leases: 2019-2025

Historic Operating Leases for Assembly Biosciences (ASMB) over the last 7 years, with Sep 2025 value amounting to $2.2 million.

  • Assembly Biosciences' Operating Leases rose 1853.10% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 1853.10%. This contributed to the annual value of $2.6 million for FY2024, which is 134.22% up from last year.
  • Assembly Biosciences' Operating Leases amounted to $2.2 million in Q3 2025, which was down 6.13% from $2.4 million recorded in Q2 2025.
  • Assembly Biosciences' 5-year Operating Leases high stood at $5.6 million for Q1 2021, and its period low was $50,000 during Q3 2023.
  • Over the past 3 years, Assembly Biosciences' median Operating Leases value was $791,000 (recorded in 2024), while the average stood at $1.1 million.
  • Its Operating Leases has fluctuated over the past 5 years, first plummeted by 96.96% in 2022, then skyrocketed by 1,853.10% in 2025.
  • Quarterly analysis of 5 years shows Assembly Biosciences' Operating Leases stood at $3.3 million in 2021, then plummeted by 96.96% to $101,000 in 2022, then surged by 1,010.89% to $1.1 million in 2023, then soared by 134.22% to $2.6 million in 2024, then soared by 1,853.10% to $2.2 million in 2025.
  • Its Operating Leases was $2.2 million in Q3 2025, compared to $2.4 million in Q2 2025 and $2.5 million in Q1 2025.